Clinical experience and results of a sentinel health investigation related to indoor fungal exposure

Environmental Health Perspectives

Volumn 107, Issue SUPPL. 3, 1999, Pages 489-494

  Johanning, Eckardt ^a,b   Landsbergis, Paul ^c   Gareis, Manfred ^d   Yang, Chin S ^e   Olmsted, Ed ^f  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b E New York Occup Environ Hlth C   (United States)

^c WEILL CORNELL MEDICAL COLLEGE   (United States)

^d FEDERAL RESEARCH INSTITUTE OF NUTRITION AND FOOD   (Germany)

^e P and K Microbiology Services Inc   (United States)

^f Olmsted Environmental Services Inc   (United States)

Author keywords

Allergy; Bioaerosol; Exposure; Fungi; Health; Morbidity; Mycotoxins; Stachybotrys; Toxicity

Indexed keywords

FUNGUS ANTIBODY; IMMUNOGLOBULIN E ANTIBODY; IMMUNOGLOBULIN G ANTIBODY;

ADOLESCENT; ADULT; AIR ANALYSIS; AMBIENT AIR; CENTRAL NERVOUS SYSTEM DISEASE; CHILD; CONFERENCE PAPER; ENVIRONMENTAL HEALTH; EXPOSURE; FEMALE; FUNGUS; HOUSING; HUMAN; HYPHOMYCETES; MAJOR CLINICAL STUDY; MALE; MUCOSA; PRIORITY JOURNAL; RESPIRATORY TRACT DISEASE; SKIN DISEASE;

EID: 0032811168     PISSN: 00916765     EISSN: None     Source Type: Journal    
DOI: 10.1289/ehp.99107s3489     Document Type: Conference Paper

References (26)

1. Husman T. Health effects of indoor-air microorganism. Scand J Work Environ Health 22:5-13 (1996).
2. Reijula K. Building with moisture problems - a new challenge to occupational health care. Scand J Work Environ Health 22:1-3 (1996).
3. Hintikka E-L. Human stachybotryotoxicosis. In: Mycotoxic Fungi, Mycotoxins, Mycotoxicoses, Vol 3 (Wyllie TD, Morehouse LG, eds). New York:Marcel Dekker, 1978;87.
4. Croft WA, Jarvis BB, Yatawara CS. Airborne outbreak of trichothecene toxicosis. Atmos Environ 20:549-552 (1986).
5. Mainville C, Auger PL, Smoagiewica W, Necukcea D, Neculcea J, Levesqye M. Mycotoxins and chronic fatigue syndrome in a hospital. In: Healthy Buildings Conference (Andersson K, ed). Stockholm:Swedish Council of Building Research, 1988;1-10.
6. Auger PL, Gourdeau P, Miller JD. Clinical experience with patients suffering from a chronic fatigue-like syndrome and repeated upper respiratory infections in relation to airborne molds. Am J Ind Med 25(1):41-42 (1994).
7. Johanning E, Auger PL, Reijula K. Building-related illnesses. N Engl J Med 338(15):1070 (1998).
8. Montaña E, Etzel RA, Allan T, Horgan TE, Dearborn DG. Environmental risk factors associated with pediatric idiopathic pulmonary hemorrhage and hemosiderosis in a Cleveland Community. Pediatrics 99(1):1-8 (1997).
9. Sorenson B, Kullman G, Hintz P. NIOSH Health Hazard Evaluation Report. HETA 95-0160-2571. Morgantown, WV:Centers for Disease Control and Prevention, 1996.
10. Etzel RA, Montaña E, Sorenson WG, Kullman GJ, Allan TM, Dearborn DG. Acute pulmonary hemorrhage in infants associated with exposure to Stachybotrys atra and other fungi. Arch Pediatr Adolesc Med 152:757-62 (1998).
11. Johanning E, Biagini R, Hull D, Morey P, Jarvis B, Landbergis P. Health and immunology study following exposure to toxigenic fungi (Stachybotrys atra) in a water-damaged office environment. Int Arch Occup Environ Health 68(4):207-218 (1996).
12. Johanning E. Stachybotrys revisited. Clin Toxicol 36(6):629-631 (1998).
13. Hodgson MJ, Morey P, Leung WY, Morrow L, Jarvis BB, Robbins H, Halsey JF, Storey E. Building-associated pulmonary disease from exposure to Stachybotrys chartarum and Aspergillus versicolor. J Occup Environ Med 40(3):241-249 (1998).
14. Corrier DE. Mycotoxicosis: mechanism of immunosuppression. Vet Immunopathol 30:73-87 (1991).
15. Sharma RP. Immunotoxic effects of mycotoxins. In: Mycotoxins and Phytoalexins (Sharma RP, Salunkhe DK, eds). Boca Raton, FL:CRC Press, 1991;81-99.
16. Nikulin M, Pasanen AL, Berg S, Hintikka EL. Stachybotrys atra growth and toxin production in some building materials and fodder under different relative humidities. Appl Environ Microbiol 60:3421-3424 (1994).
17. Johanning E, Gareis M, Yang CS, Hintikka EL, Nikulin M, Jarvis B, Dietrich R. Toxicity screening of fungal (Stachybotrys chartarum) field samples and indoor exposure. Mycotoxin Res 14:60-73 (1998).
18. Dillon HK, Heinsohn PA, Miller JO (eds). Field Guide for the Determination of Biological Contaminants in Environmental Samples. AIHA Biosafety Committee. Fairfax, VA:American Industrial Hygiene Association, 1996.
19. Hanelt M, Gareis M, Kollarczik B. Cytotoxicity of mycotoxins evaluated by the MTT-cell culture assay. Mycopathologica 128:167-174 (1994).
20. Gareis ML. Cytotoxicity testing of samples originating from buildings. In: Fungi and Bacteria in Indoor Air Environments (Johanning E, Yang CS, eds). Proceedings of the International Conference, 6-7 October 1994, Saratoga Springs, New York. Albany, NY:Eastern New York Occupational Health Program, 1995;139-145.
21. Rosenstreich DL, Eggleston P, Kattan M, Baker D, Slavin RG, Gergen P, Mitchell H, McNiff-Mortimer K, Lynn H, Ownby D, et al. The role of cockroach allergy and exposure to cockroach allergen in causing morbidity among inner-city children with asthma [see comments] N Engl J Med 336(19):1356-1363 (1997).
22. Peat JK, Dickerson J, Li J. Effects of damp and mould in the home on respiratory health: a review of the literature. Allergy 58:120-128 (1998).
23. Dales R, Miller D, White J, Dulberg C, Lazarovitz AI. Influence of residential fungal contamination on peripheral blood lymphocyte population in children. Arch Environ Health 53 (3):190-195 (1998).
24. Polgar C, Promadhat V. Pulmonary Function Testing in Children: Techniques and Standards. Philadelphia:W.B. Saunders, 1971;100-153.
25. Knudson RJ, Slatin R, Lebowitz M, Burrows B. The maximal expiratory flow-volume curve. Normal standards, variability, and effects of age. Am Rev Respir Dis 113:557-600 (1976)
26. Knudson RJ, Lebowitz M, Holberg CJE, Burrows B. Changes in the normal maximal expiratory row-volume curve with aging. Am Rev Respir Dis 127:725-734 (1983).